(Q35548696)

8 August 2017

1 reference

title

Nasopharyngeal carcinomas: an update (English)

1 reference

ORCID Public Data File 2021

8 August 2017

1 reference

author name string

Spano JP

1

1 reference

8 August 2017

Busson P

2

1 reference

8 August 2017

Atlan D

3

1 reference

8 August 2017

Bourhis J

4

1 reference

8 August 2017

Pignon JP

5

1 reference

8 August 2017

Esteban C

6

1 reference

8 August 2017

Armand JP

7

1 reference

8 August 2017

1 October 2003

1 reference

European Journal of Cancer

8 August 2017

1 reference

8 August 2017

39

1 reference

8 August 2017

15

1 reference

8 August 2017

2121-2135

1 reference

8 August 2017

Nasopharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progr

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Autoantibodies to tubulin are specifically associated with the young age onset of the nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Diet, living conditions and nasopharyngeal carcinoma in Tunisia--a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Carcinoma of the nasopharynx: analysis of treatment results in 167 consecutively admitted patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

A protective association between the HLA-A2 antigen and nasopharyngeal carcinoma in US Caucasians.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Immunogenetic aspects of nasopharyngeal carcinoma. IV. Increased risk in Chinese of nasopharyngeal carcinoma associated with a Chinese-related HLA profile (A2, Singapore 2)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Haplotypes of human leukocyte antigens among patients with nasopharyngeal cancer in Greece

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA regions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Occupational and other non-dietary risk factors for nasopharyngeal carcinoma in Guangzhou, China

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Environmental and dietary risk factors for nasopharyngeal carcinoma: a case-control study in Zangwu County, Guangxi, China

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Tobacco use and nasopharyngeal carcinoma in a cohort of US veterans

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Increased morbidity from nasopharyngeal carcinoma and chronic pharyngitis or sinusitis among workers at a newspaper printing company

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Identification of integrated Epstein-Barr virus in nasopharyngeal carcinoma using pulse field gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

bcl-xL and RAG genes are induced and the response to IL-2 enhanced in EmuEBNA-1 transgenic mouse lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

LMP1 structure and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

An Epstein-Barr virus protein interacts with Notch

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Detection of cell free Epstein-Barr virus DNA in sera from patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

In nasopharyngeal carcinoma-bearing patients, tumors and lymphocytes are infected by different Epstein-Barr virus strains

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Identification of Epstein-Barr virus strain variants in hairy leukoplakia and peripheral blood by use of a heteroduplex tracking assay

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Nasopharyngeal carcinoma: clinical course and results of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Malignant tumors of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

The efficacy of fiberoptic endoscopic examination and biopsy in the detection of early nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Relationship between nasopharyngeal carcinoma and high antibody titers to Epstein-Barr virus-specific thymidine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Epstein‐barr virus detection in neck metastases by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Diagnosis of Nasopharyngeal Carcinoma by DNA Amplification of Tissue Obtained by Fine-Needle Aspiration

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Nasopharyngeal carcinoma. Pattern of tumor regression after radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Evaluation of skull base erosion in nasopharyngeal carcinoma: comparison of plain radiography and computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Power Doppler sonography of cervical lymphadenopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

A retrospective comparison between different stage classifications for nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Is the 1997 AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Carcinoma of the nasopharynx: factors affecting prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Cranial nerve involvement and base of the skull erosion in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Response of cranial nerve abnormalities in nasopharyngeal carcinoma to radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Prognostic factors in patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Computed Tomographic Density of Metastatic Lymph Nodes as a Treatment-Related Prognostic Factor in Advanced Head and Neck Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Nasopharyngeal carcinoma in the second decade of life

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Carcinoma of the nasopharynx in young patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Cancer of the nasopharynx in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma on local control and short-term survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Management of unresectable malignant tumors at the skull base using concomitant chemotherapy and radiotherapy with accelerated fractionation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Computed tomography in nasopharyngeal carcinoma: Part II: Impact on survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Analysis of failures after definitive irradiation for epidermoid carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Megavoltage irradiation of epithelial tumors of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

A clinical study of 407 cases of nasopharyngeal carcinoma in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Radiation Therapy of Recurrent Nasopharyngeal Carcinoma: Report on 219 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Nasopharyngeal carcinomas: analysis of patient, tumor and treatment characteristics determining outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Symptomatic hypothalamic-pituitary dysfunction in nasopharyngeal carcinoma patients following radiation therapy: a retrospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Quality of life of nasopharyngeal carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Proton therapy for carcinoma of the nasopharynx: a study in comparative treatment planning

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Early tumour response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Improved local control for early T-stage nasopharyngeal carcinoma – a tale of two hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Dose-response analysis for nasopharyngeal carcinoma: an historical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Modulation of cellular response to ionizing radiation: towards new molecular targets?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

The molecular regulation of apoptosis and implications for radiation oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Radiation-induced expression of functional Fas ligand in EBV-positive human nasopharyngeal carcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

UCNT: chemocurable sometimes, but not very often

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

The promising role of safe initial non-cisplatin-containing combination chemotherapy in nasopharyngeal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Multicenter phase II trial of mitoxantrone in patients with advanced nasopharyngeal carcinoma in Southeast Asia: an Asian-Oceanian Clinical Oncology Association Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

High Complete Response in Advanced Nasopharyngeal Carcinoma With Bleomycin, Epirubicin, and Cisplatin Before Radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal ca

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Carcinoma of the nasopharynx. An analysis of 91 cases and a comparison of differing treatment approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: an analysis of 1301 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Treatment of Locally Recurrent Carcinoma of the Nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Permanent iodine-125 (I-125) boost implants after external radiation therapy in nasopharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

High dose rate intracavitary brachytherapy in the treatment of nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

Apoptosis induced by low-dose paclitaxel is associated with p53 upregulation in nasopharyngeal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900367-8

7 January 2021

10.1016/S0959-8049(03)00367-8

Identifiers

DOI

1 reference

8 August 2017

1 reference